Yes, elevated prolactin levels definitively cause infertility in both men and women.
Elevated prolactin directly impairs gonadal function and is a well-established endocrine cause of infertility that requires treatment in patients attempting to conceive 1.
Mechanism of Infertility
Hyperprolactinemia disrupts the hypothalamic-pituitary-ovarian/testicular axis, leading to:
In Women:
- Chronic anovulation (most common)
- Luteal phase insufficiency in cycling women
- Amenorrhea
- Recurrent miscarriage
- Impaired endometrial receptivity 2, 3
In Men:
- Hypogonadotropic hypogonadism
- Impaired spermatogenesis
- Reduced sperm count and motility
- Sexual dysfunction and impotence
- Small testicular and prostate size 1, 4
Clinical Presentation
The severity of reproductive dysfunction correlates with prolactin levels. Women with prolactinomas typically present with galactorrhea, menstrual irregularities, and infertility 1. Men present with infertility, hypogonadism, impotence, and occasionally galactorrhea 1, 4. Notably, even mild-to-moderate hyperprolactinemia without other symptoms can cause infertility 2.
Diagnostic Approach
- Confirm hyperprolactinemia with a single measurement above the upper limit of normal (avoiding venipuncture stress) 1
- Repeat testing on a second sample to confirm persistence 2
- Exclude macroprolactin in asymptomatic patients 1
- Rule out secondary causes: medications (antipsychotics, antidepressants), renal failure, hypothyroidism 1
- Obtain pituitary MRI to identify prolactinomas or other pituitary/parasellar tumors 1
Important Caveat
In patients with very large pituitary tumors but only mildly elevated prolactin, perform serial dilution of serum samples to exclude the "hook effect" (falsely low prolactin from immunoassay artifact) 1.
Treatment and Fertility Restoration
Dopamine agonist therapy is the first-line treatment and highly effective for restoring fertility 1:
Cabergoline (Preferred Agent)
- Normalizes prolactin in 92% of patients with microprolactinomas and 77% with macroadenomas 1
- Restores menses in 82% of women with amenorrhea 1
- Restores sperm count and motility in men within 6 months 1
- Dose range: 0.25-3 mg/week (occasionally up to 11 mg/week) 1
- Superior efficacy and tolerability compared to bromocriptine 1
Treatment Efficacy
Among 271 women with hyperprolactinemia followed up to 29 years, dopamine agonist therapy normalized prolactin in 71% and achieved tumor shrinkage in 80% 1. In men, 80% achieve prolactin normalization with dopamine agonists regardless of tumor size 1.
Treatment Algorithm for Infertility
For symptomatic patients with prolactinomas (micro or macro):
- Start cabergoline at low dose
- Monitor prolactin monthly to guide dose escalation
- Continue until prolactin normalizes and fertility is restored 1
For asymptomatic microprolactinomas:
- Treatment not required unless patient has amenorrhea or desires fertility
- If amenorrhea present: treat with dopamine agonist OR oral contraceptives 1
For patients attempting pregnancy:
- Any confirmed hyperprolactinemia should be treated, even if mild 2
- Discontinue dopamine agonist as soon as pregnancy is confirmed 1
- Risk of tumor growth during pregnancy is low for microprolactinomas (<5%) 5
Treatment-Resistant Cases
For patients not achieving normal prolactin or adequate tumor shrinkage on standard doses:
- Increase the dose rather than proceeding to surgery 1
- If bromocriptine-resistant, switch to cabergoline 1
- Surgery reserved for dopamine agonist intolerance or true resistance 1
Key Clinical Pitfalls
- Don't dismiss mild hyperprolactinemia in infertile patients—even modest elevations can impair fertility 2
- Don't overlook male partners—hyperprolactinemia is detected in 4% of infertile men and is treatable 4
- Don't continue dopamine agonists after conception is confirmed (discontinue immediately) 1
- Don't assume all elevated prolactin is pathologic—exclude macroprolactin, medications, stress, and physiologic causes first 1, 2